Localization of chemical messengers in magnocellular neurons of the hypothalamic supraoptic and paraventricular nuclei: an immunohistochemical study using experimental manipulations.
Indirect immunofluorescence histochemistry was used to investigate the distribution and extent of co-localization of chemical messengers in magnocellular neurons of the supraoptic and paraventricular nuclei. In order to increase the number of neurons immunoreactive to the antisera used, experimental manipulations were employed. The homozygous Brattleboro (diabetes insipidus) rat was also investigated. In untreated rats, only vasopressin- and oxytocin-like immunoreactivities could be observed. Colchicine treatment alone resulted in appearance of galanin-, dynorphin-, cholecystokinin-, [Leu]enkephalin- and thyrotropin-releasing hormone-positive cells. In hypophysectomized rats, all these markers, except tyrosine hydroxylase, showed substantial further increases. In addition, peptide histidine-isoleucine-immunoreactive cell bodies could now be seen. After salt-loading alone, tyrosine hydroxylase-like immunoreactivity was markedly increased, whereas vasopressin- and oxytocin-like immunoreactivity were very weak or undetectable. When salt-loaded rats received colchicine, corticotropin-releasing factor- and peptide histidine-isoleucine-like immunoreactivity in addition increased, whereas galanin- and dynorphin-like immunoreactivity markedly decreased. The Brattleboro rats resembled untreated rats, except their lack of vasopressin-like immunoreactivity, the marked increase in tyrosine hydroxylase-like immunoreactivity, and smaller increase in galanin- and dynorphin-like immunoreactivity. Addition of colchicine to Brattleboro rats resulted in some distinct further changes in that dynorphin-like immunoreactivity decreased in some neurons and that [Leu]enkephalin-, corticotropin-releasing factor- and peptide histidine-isoleucine-like immunoreactivity increased substantially. Several similarities could be observed between the salt-loaded and Brattleboro rats, with or without colchicine. However, a marked difference in immunoreactive [Leu]enkephalin levels was observed with no difference in dynorphin-like immunoreactivity, and opposite changes in galanin-like immunoreactivity. The results confirm the traditional view that hypothalamic magnocellular neurons in the supraoptic and paraventricular nuclei contain two separate cell populations, characterized by vasopressin and oxytocin, respectively, and that they contain additional messenger molecules in specific patterns. Vasopressin-containing neurons primarily express tyrosine hydroxylase, galanin, dynorphin, [Leu]enkephalin and peptide histidine-isoleucine, and to a minor extent cholecystokinin and thyrotropin-releasing hormone. Oxytocin-containing neurons mainly have cholecystokinin and corticotropin-releasing factor, and to a minor extent galanin, dynorphin, [Leu]enkephalin and thyrotropin-releasing hormone. Furthermore, our results detail individual co-existence situations among these putative messenger molecules. Thus, magnocellular neurons respond in a differential way to various stimuli and they store multiple bioactive substances in specific combinations.
Meister
B
B
Department of Histology and Neurobiology, Karolinska Institute, Stockholm, Sweden.
Villar
M J
MJ
Ceccatelli
S
S
Hökfelt
T
T
D000818:Animals; D002766:Cholecystokinin / Q000502:physiology; D003078:Colchicine / Q000494:pharmacology; D003346:Corticotropin-Releasing Hormone / Q000502:physiology; D004285:Dogs; D004399:Dynorphins / Q000502:physiology; D004745:Enkephalins / Q000502:physiology; D005455:Fluorescent Antibody Technique; D019004:Galanin; D007016:Hypophysectomy; D007150:Immunohistochemistry; D010121:Oxytocin / Q000502:physiology; D010286:Paraventricular Hypothalamic Nucleus / Q000033:anatomy & histology / Q000737:chemistry / Q000378:metabolism*; D010451:Peptide PHI / Q000502:physiology; D010455:Peptides / Q000502:physiology; D051381:Rats; D011910:Rats, Brattleboro; D011919:Rats, Inbred Strains; D013495:Supraoptic Nucleus / Q000033:anatomy & histology / Q000737:chemistry / Q000378:metabolism*; D013973:Thyrotropin-Releasing Hormone / Q000502:physiology; D014446:Tyrosine 3-Monooxygenase / Q000502:physiology; D014667:Vasopressins / Q000502:physiology
D004745:Enkephalins; D010451:Peptide PHI; D010455:Peptides; D014667:Vasopressins; D010121:Oxytocin; D013973:Thyrotropin-Releasing Hormone; D004399:Dynorphins; D019004:Galanin; D002766:Cholecystokinin; D003346:Corticotropin-Releasing Hormone; D014446:Tyrosine 3-Monooxygenase; D003078:Colchicine